|
KPNA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.561200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.384300E-03 |
| Normal-vs-Stage2 |
2.308600E-01 |
| Normal-vs-Stage3 |
8.940000E-03 |
| Normal-vs-Stage4 |
2.083900E-02 |
| Stage1-vs-Stage2 |
7.029400E-01 |
| Stage1-vs-Stage3 |
5.582400E-01 |
| Stage1-vs-Stage4 |
7.512600E-01 |
| Stage2-vs-Stage3 |
5.149200E-01 |
| Stage2-vs-Stage4 |
6.076000E-01 |
| Stage3-vs-Stage4 |
8.730400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.905870E-02 |
| Normal-vs-AfricanAmerican |
4.89770000000611E-06 |
| Normal-vs-Asian |
9.998400E-01 |
| Caucasian-vs-AfricanAmerican |
3.301900E-03 |
| Caucasian-vs-Asian |
4.094000E-01 |
| AfricanAmerican-vs-Asian |
3.648100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.697800E-03 |
| Normal-vs-Female |
5.776200E-03 |
| Male-vs-Female |
8.727600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.244200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.130270E-02 |
| Normal-vs-Age(61-80Yrs) |
1.491570E-02 |
| Normal-vs-Age(81-100Yrs) |
1.006490E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.557200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.065400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.347600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.722600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.396600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.908800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.843550E-01 |
| Normal-vs-Grade 2 |
6.183700E-02 |
| Normal-vs-Grade 3 |
1.060350E-03 |
| Normal-vs-Grade 4 |
9.024400E-03 |
| Grade 1-vs-Grade 2 |
7.266200E-01 |
| Grade 1-vs-Grade 3 |
8.049400E-01 |
| Grade 1-vs-Grade 4 |
8.019400E-01 |
| Grade 2-vs-Grade 3 |
8.306100E-02 |
| Grade 2-vs-Grade 4 |
2.122600E-01 |
| Grade 3-vs-Grade 4 |
9.170200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.252750E-01 |
| Normal-vs-ccB subtype |
6.343600E-02 |
| ccA subtype-vs-ccB subtype |
5.252800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.504020E-02 |
| Normal-vs-N1 |
6.109400E-01 |
| N0-vs-N1 |
6.454000E-01 |
|
|
